Cysts Can Be Classified by Anatomic Location, Embryologic Derivation Or Histologic Features
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Bartholin's Cyst, Also Called a Bartholin's Duct Cyst, Is a Small Growth Just Inside the Opening of a Woman’S Vagina
Saint Mary’s Hospital Bartholin’s cyst Information For Patients 2 Welcome to the Gynaecology Services at Saint Mary’s Hospital This leaflet aims to give you some general information about Bartholin’s cysts and help to answer any questions you may have. It is intended only as a guide and there will be an opportunity for you to talk to your nurse and doctor about your care and treatment. What is a Bartholin;s cyst? A Bartholin's cyst, also called a Bartholin's duct cyst, is a small growth just inside the opening of a woman’s vagina. Cysts are small fluid-filled sacs that are usually harmless. Normal anatomy Bartholin gland cyst Bartholin’s glands The Bartholin’s glands are a pair of pea-sized glands that are found just behind and either side of the labia minora (the inner pair of lips surrounding the entrance to the vagina). The glands are not usually noticeable because they are rarely larger than 1cm (0.4 inches) across. 3 The Bartholin’s glands secrete fluid that acts as a lubricant during sexual intercourse. The fluid travels down tiny ducts (tubes) that are about 2cm (0.8 inches) long into the vagina. If the ducts become blocked, they will fill with fluid and expand. This then becomes a cyst. How common is a Bartholin’s cyst? According to estimates, around 2% (1 in 50) of women will experience a Bartholin’s cyst at some point. The condition usually affects sexually active women between the ages of 20 and 30. The Bartholin’s glands do not start functioning until puberty, so Bartholin’s cysts do not usually affect children. -
Dermatologists' Perceptions on the Utility and Limitations
RESEARCH/Original Article Journal of Telemedicine and Telecare 2021, Vol. 27(3) 166–173 Dermatologists’ perceptions on the ! The Author(s) 2019 utility and limitations of teledermatology Article reuse guidelines: sagepub.com/journals-permissions after examining 55,000 lesions DOI: 10.1177/1357633X19864829 journals.sagepub.com/home/jtt Mara Giavina Bianchi , Andre Santos and Eduardo Cordioli Abstract Introduction: Few studies have assessed the perception of teledermatologists about the utility and limitations of teledermatology, especially to diagnose a broad range of skin diseases. This study aimed to evaluate dermatologists’ confidence in teledermatology, its utility and limitations for dermatological conditions in primary care. Methods: An analytical study that used a survey for dermatologists who diagnosed 30,916 patients with 55,012 lesions through teledermatology during a 1-year project in S~ao Paulo, Brazil. Results: Dermatologists found teledermatology useful for triage and diagnosis, especially for xerotic eczema, pigmen- tary disorders and superficial infections. Their confidence in teledermatology was statistically higher by the end of the project (p ¼ 0.0012). Limitations included some technical issues and the impossibility to suggest how soon the patient should be assisted face-to-face by a dermatologist. The most treatable group of diseases by teledermatology was superficial infections (92%). The use of dermoscopy images would significantly increase the confidence to treat atypical naevi and malignant tumours (p < 0.0001 and p ¼ 0.0003 respectively). Follow-ups by teledermatology or feedback from primary-care physicians would be desirable, according to the dermatologists. Discussion: We found it interesting that dermatologists became increasingly confident in teledermatology after the project and how they classified teledermatology as useful for triage, diagnosis and even treatment of most types of skin conditions followed at primary care. -
The Nutrition and Food Web Archive Medical Terminology Book
The Nutrition and Food Web Archive Medical Terminology Book www.nafwa. -
Practical Applications of Molecular Testing in the Cytologic Diagnosis of Pancreatic Cysts
Review Practical Applications of Molecular Testing in the Cytologic Diagnosis of Pancreatic Cysts Mingjuan Lisa Zhang * and Martha B. Pitman * Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA * Correspondence: [email protected] (M.L.Z.); [email protected] (M.B.P.) Abstract: Mucinous pancreatic cysts are precursor lesions of ductal adenocarcinoma. Discoveries of the molecular alterations detectable in pancreatic cyst fluid (PCF) that help to define a mucinous cyst and its risk for malignancy have led to more routine molecular testing in the preoperative evaluation of these cysts. The differential diagnosis of pancreatic cysts is broad and ranges from non-neoplastic to premalignant to malignant cysts. Not all pancreatic cysts—including mucinous cysts—require surgical intervention, and it is the preoperative evaluation with imaging and PCF analysis that determines patient management. PCF analysis includes biochemical and molecular analysis, both of which are ancillary studies that add significant value to the final cytological diagnosis. While testing PCF for carcinoembryonic antigen (CEA) is a very specific test for a mucinous etiology, many mucinous cysts do not have an elevated CEA. In these cases, detection of a KRAS and/or GNAS mutation is highly specific for a mucinous etiology, with GNAS mutations supporting an intraductal papillary mucinous neoplasm. Late mutations in the progression to malignancy such as those found in TP53, p16/CDKN2A, and/or SMAD4 support a high-risk lesion. This review highlights PCF triage and analysis of pancreatic cysts for optimal cytological diagnosis. Keywords: pancreatic cytology; pancreatic cyst fluid; cyst fluid triage; molecular testing; mucinous cyst; intraductal papillary mucinous neoplasm; mucinous cystic neoplasm Citation: Zhang, M.L.; Pitman, M.B. -
Cryotherapy in the Treatment of Glandular
Cryotherapy in the treatment of glandular odontogenic cyst: case report and review Crioterapia no tratamento de cisto odontogênico glandular: relato de caso e revisão Milene Borges Campagnaro* Raquel Medeiros Farias* Roger Correa de Barros Berthold** Márcia Rejane Brücker*** Fábio Dal Moro Maito**** Claiton Heitz***** Objective: The Glandular Odontogenic Cyst (GOC) is Introduction a rare benign odontogenic lesion, of considerable ag- gression, and often incorrectly diagnosed. We present a Glandular Odontogenic Cyst (GOC) was first patient with a Glandular Odontogenic Cyst in the pos- described by Gardner in 1988 as a distinct clinical terior mandible, its evolution, treatment, and follow-up. pathologic entity, and it was included in the WHO Case report: A female patient, 45 years old, was referred histological typing of odontogenic tumors under to the Oral and Maxillofacial Surgery and Traumatology GOC or sialo-odontogenic cyst1-5. Division at Cristo Redentor Hospital, Porto Alegre, Bra- Glandular Odontogenic Cyst is a rare lesion, of zil, for the assessment of a painful edema on the right considerable aggressive behavior, originated at the hemiface. A unilocular area with well-defined borders 1-5 in the retromolar region, posterior to the third molar on areas of dental support . Clinically, the most affec- the right side of the mandible. The histopathological ted site is the anterior part of the mandible and it examination suggested GOC. Final considerations: The mostly occurs in middle-aged patients with a slight Glandular Odontogenic Cyst needs a complete clinical male prevalence2,4-8. Epidemiological features are assessment associated with image analyses, and espe- scarce due to the rarity of the lesion and a review in cially, with histopathology for the correct diagnosis of 2008 pointed 111 cases published in the literature6. -
Glandular Odontogenic Cyst: Case Series and Summary of the Literature
502 > CLINICAL REVIEW http://dx.doi.org/10.17159/2519-0105/2019/v74no9a6 Glandular odontogenic cyst: case series and summary of the literature SADJ October 2019, Vol. 74 No. 9 p502 - p507 F Opondo1, S Shaik2, J Opperman3, CJ Nortjé4 ABSTRACT The glandular odontogenic cyst (GOC) remains a Histologically, it may mimic any one of a dentigerous rare entity. It was initially named “sialo-odontogenic cyst, radicular cyst, surgical ciliated cyst, lateral perio- cyst” by Padayachee and Van Wyk in 1987 when dontal cyst or a botryoid odontogenic cyst. Importantly, they reported the first two cases. Thereafter the the features of a cystic lesion with squamous and term glandular odontogenic cyst was suggested mucous epithelial elements may cause it to be mis- by Gardner et al. in 1988 and was subsequently diagnosed as a central mucoepidermoid carcinoma. adopted by the WHO.1 With more comprehensive diagnostic criteria, at least 180 In addition to its rarity, it has non-pathognomonic cases have so far been reported in the English literature.4 clinical and radiological features and hence can It is therefore reasonable to assume that the previous mimic other lesions. Since its recognition as an rarity of this entity may be attributable to misdiagnosis. entity by the WHO in 1992, only two further cases of glandular odontogenic cyst have been seen at CASE 1 the authors’ institution and are hereby reported together with a summary of the review articles in A 60-year-old man presented at the diagnostic clinic at the English literature. Tygerberg Oral Health Centre with an asymptomatic swelling of the anterior mandible. -
Proliferating Trichilemmal Cyst of the Scalp: Nine Cases and Literature Review
Otorhinolaryngology-Head and Neck Surgery Research Article ISSN: 2398-4937 Proliferating trichilemmal cyst of the scalp: Nine cases and literature review ElBenaye J1,3*, Sinaa M2,3, Elkhachine Y1,3, Sakkah A1,3, Jakar A1 and Elhaouri M1 1Department of Dermatology, Moulay Ismail Military Hospital, Meknes, Morocco 2Department of Cytopathology, Moulay Ismail Military Hospital, Meknes, Morocco 3Department of Medicine and Pharmacy, Sidi Mohammed Ben Abdellah University (USMBA), Fes, Morocco Abstract Background: proliferating trichilemmal cyst (PTC) is a rare adnexal tumor, primarily sitting on the scalp of elderly women. Its evolution is generally benign despite the rare malignant cases described. We report a series of 9 cases of which one is malignant and metastatic. Material and methods: We retrospectively reviewed data of all patients with PTC seen at department of dermatology in the Meknes military hospital, between January 2013 and December 2017. Results: Nine cases of PTC were diagnosed, which 8 in elderly women, with 62 years mean age. Trauma was found in one third of cases correlated with rapid growth of the tumor. The latter was symptomatic in 2/3 of the cases. Ulceration involved only the malignant case. The size varied from 1,5 to 12 cm. Recurrence after surgery was noted in 2 cases (malignant tumor and multi-cystic tumor). Discussion: PTC appears to have a well-distinguished profile of the simple trichilemmal cyst. Some clinical and histological features may constitute prognostic factors of aggressiveness. Histological and immunohistochemical study is crucial in the management. A large excision remains the only guarantee of complete remission without recurrence or metastasis. -
2016 Essentials of Dermatopathology Slide Library Handout Book
2016 Essentials of Dermatopathology Slide Library Handout Book April 8-10, 2016 JW Marriott Houston Downtown Houston, TX USA CASE #01 -- SLIDE #01 Diagnosis: Nodular fasciitis Case Summary: 12 year old male with a rapidly growing temple mass. Present for 4 weeks. Nodular fasciitis is a self-limited pseudosarcomatous proliferation that may cause clinical alarm due to its rapid growth. It is most common in young adults but occurs across a wide age range. This lesion is typically 3-5 cm and composed of bland fibroblasts and myofibroblasts without significant cytologic atypia arranged in a loose storiform pattern with areas of extravasated red blood cells. Mitoses may be numerous, but atypical mitotic figures are absent. Nodular fasciitis is a benign process, and recurrence is very rare (1%). Recent work has shown that the MYH9-USP6 gene fusion is present in approximately 90% of cases, and molecular techniques to show USP6 gene rearrangement may be a helpful ancillary tool in difficult cases or on small biopsy samples. Weiss SW, Goldblum JR. Enzinger and Weiss’s Soft Tissue Tumors, 5th edition. Mosby Elsevier. 2008. Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011 Oct;91(10):1427-33. Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch. 2013 Jul;463(1):97-8. CONTRIBUTED BY KAREN FRITCHIE, MD 1 CASE #02 -- SLIDE #02 Diagnosis: Cellular fibrous histiocytoma Case Summary: 12 year old female with wrist mass. -
Non-Cancerous Breast Conditions Fibrosis and Simple Cysts in The
cancer.org | 1.800.227.2345 Non-cancerous Breast Conditions ● Fibrosis and Simple Cysts ● Ductal or Lobular Hyperplasia ● Lobular Carcinoma in Situ (LCIS) ● Adenosis ● Fibroadenomas ● Phyllodes Tumors ● Intraductal Papillomas ● Granular Cell Tumors ● Fat Necrosis and Oil Cysts ● Mastitis ● Duct Ectasia ● Other Non-cancerous Breast Conditions Fibrosis and Simple Cysts in the Breast Many breast lumps turn out to be caused by fibrosis and/or cysts, which are non- cancerous (benign) changes in breast tissue that many women get at some time in their lives. These changes are sometimes called fibrocystic changes, and used to be called fibrocystic disease. 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 Fibrosis and cysts are most common in women of child-bearing age, but they can affect women of any age. They may be found in different parts of the breast and in both breasts at the same time. Fibrosis Fibrosis refers to a large amount of fibrous tissue, the same tissue that ligaments and scar tissue are made of. Areas of fibrosis feel rubbery, firm, or hard to the touch. Cysts Cysts are fluid-filled, round or oval sacs within the breasts. They are often felt as a round, movable lump, which might also be tender to the touch. They are most often found in women in their 40s, but they can occur in women of any age. Monthly hormone changes often cause cysts to get bigger and become painful and sometimes more noticeable just before the menstrual period. Cysts begin when fluid starts to build up inside the breast glands. Microcysts (tiny, microscopic cysts) are too small to feel and are found only when tissue is looked at under a microscope. -
Histopathological Profile of Surgically Excised Scalp and Skull Lesions Asuman Kilitci¹ , Ziya Asan²
DOI: 10.5152/cjms.2018.442 Original Article Histopathological Profile of Surgically Excised Scalp and Skull Lesions Asuman Kilitci¹ , Ziya Asan² 1Department of Pathology, Ahi Evran University School of Medicine, Kırşehir, Turkey ²Department of Neurosurgery, Ahi Evran University School of Medicine, Kırşehir, Turkey ORCID ID of the author: A.K. 0000-0002-5489-2222; Z.A. 0000-0001-8468-9156 Cite this article as: Kilitci A, Asan Z. Histopathological Profile of Surgically Excised Scalp and Skull Lesions. Cyprus J Med Sci 2018; 3: 63-7. BACKGROUND/AIMS Although subcutaneous lesions of the scalp are more common than those of the skull, few studies in literature have assessed the frequency of scalp and skull diseases. The goal of this study was to establish the frequency and main histopathological findings of these lesions. Our study is one of the largest series and shows that the incidence of surgically excised scalp masses includes an array of diseases. MATERIAL and METHODS We reviewed 265 extracranial masses from 173 patients. The mean age of the patients, gender distribution, localization and characteristics of lesions, histopathological type and radiological features were analyzed. RESULTS One-hundred (57.8%) patients were males and 73 (42.2%) were females. The mean age was 42.98 (range, 5-87). In total, 261 were within the scalp, 1 involved the scalp and skull and 3 were within the limits of the skull. Six lesions exhibited malignant features. There were 101 trichilemmal cysts; 74 epidermal cysts; 38 intradermal nevus; 8 verruca vulgaris; -
Ovarian Cysts Before the Menopause
Information for you Published in June 2013 Ovarian cysts before the menopause About this information This information is for you if you are premenopausal (have not gone through the menopause) and your doctor thinks you might have a cyst on one or both of your ovaries. It tells you about cysts on the ovary and the tests and treatment you may be offered. This information aims to help you and your healthcare team make the best decisions about your care. It is not meant to replace advice from a doctor about your situation. What are ovaries? Ovaries are a woman’s reproductive organs that make female hormones and release an egg from a follicle (a small fluid-filled sac) each month. The follicle is usually about 2–3 cm when measured across (diameter) but sometimes can be larger. What is an ovarian cyst? An ovarian cyst is a larger fluid-filled sac (more than 3 cm in diameter) that develops on or in an ovary. A cyst can vary in size from a few centimetres to the size of a large melon. Ovarian cysts may be thin-walled and only contain fluid (known as a simple cyst) or they may be more complex, containing thick fluid, blood or solid areas. There are many different types of ovarian cyst that occur before the menopause, examples of which include: • a simple cyst, which is usually a large follicle that has continued to grow after an egg has been released; simple cysts are the most common cysts to occur before the menopause and most disappear within a few months • an endometrioma – endometriosis, where cells of the lining of the womb are found outside the womb, sometimes causes ovarian cysts and these are called endometriomas (for further information see the RCOG patient information leaflet Endometriosis: What You Need to 1 Know, available at: www.rcog.org.uk/womens-health/clinical-guidance/endometriosis-what-you- need-know) • a dermoid cyst, which develops from the cells that make eggs in the ovary, often contains substances such as hair and fat. -
Histopathology Squamous Cell Carcinoma
Squamous cell carcinoma - Mohs Ron Rapini MD No conflict of interest Josey Chair, Dept Dermatology • I am paid zero to speak at this Univ Texas Medical School at Houston MD Anderson Cancer Center course, other than travel • The tuition helps to run the ASMS programs Duplicate Actinic keratosis Actinic keratosis Rx • Whether you call it a “precancer” or • Treating orAKs is beyond this lecture “squamous cell carcinoma grade 1/2” or • Ill-defined dysplasias – usually a “field-effect” “SCC – AK type”, or “keratinocytic • Trying to eradicate totally is like playing intraepithelial neoplasia = KIN”, it still “whack a mole” so goal is to eradicate most doesn’t need Mohs surgery significant areas • Don’t over-read as invasive squamous cell ca • Cryo, curettage, laser, imiquimod, • AK and squamous cell carcinoma are often fluorouracil, diclofenac, etc multifocal with field effects in margins Keratinocytic intraepithelialDistribute Grading dysplasia in neoplasia = KIN 1, 2, 3 dysplastic nevi is analogous • Analogous to CIN, PIN, VIN 1,2,3 • Really in SKIN with most popular • NIH consensus conference 1992 system, we don’t have a “2”: recommended grading cytology despite Not lack of concordance AK = KIN-1 • I grade only cytology as mild, moderate, SCC in situ (Bowen’s) = KIN-3 Do severe 1 Lack of concordance on grading “dysplasia” in dysplastic nevi Other terms Piepkorn (J Cutan Pathol 6:542, 1992) • Bowenoid AK – “just call it found only 38% agreement SCCis?” Similar situation with KIN-2 (in between • Advanced AK – “beware” AK and SCC in situ) –